{
    "clinical_study": {
        "@rank": "114261", 
        "acronym": "MxB Po01", 
        "arm_group": {
            "arm_group_label": "dressing", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The overall rationale for this study is to evaluate the clinical performance potential for\n      Mepilex Border Post-Op in the ability to minimise the risk of blistering, maceration and\n      less dressing change due to high absorption capacity. This study is a part of Post Market\n      Clinical Follow-Up (PMCF)."
        }, 
        "brief_title": "Post Market Clinical Follow-up Study", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Hip or Knee Surgery", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          1. Age 45 years\n\n          2. Have an expected total length of stay of 4 or more days\n\n          3. Undergoing elective primary arthroplasty of the hip or knee\n\n          4. Undergoing hip surgery with a standard access\n\n          5. Give their written informed consent to participate\n\n        Exclusion Criteria\n\n          1. Dressing size does not fit the incision area\n\n          2. Known allergy hypersensitivity to any of the components of the dressing\n\n          3. Multi-trauma\n\n          4. Undergoing arthroplasty due to tumour\n\n          5. Fractures\n\n          6. Wound at the surgical site prior to surgery\n\n          7. Neurological deficit of operated side\n\n          8. Subject has documented skin disease at time of enrolment, as judged by the\n             investigator\n\n          9. Previously enrolled in the present investigation\n\n         10. Subject included in other ongoing investigation at present, as judged by the\n             investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841567", 
            "org_study_id": "MxB Po01"
        }, 
        "intervention": [
            {
                "arm_group_label": "dressing", 
                "intervention_name": "Mepilex border post. op", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "dressing", 
                "intervention_name": "Mepilex border post op", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "hip", 
            "knee"
        ], 
        "lastchanged_date": "December 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "K\u00f6ln", 
                    "country": "Germany", 
                    "zip": "50924"
                }, 
                "name": "universit\u00e4tsklinikum K\u00f6ln"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi-centre, Post CE-mark, Open Investigation to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty", 
        "overall_official": {
            "affiliation": "University Hospital Koln", 
            "last_name": "Kourosh Zarghooni, Dr. Med", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Minimize the risk of the development of blistering.", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841567"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "the performance of the dressing", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "comfort, comformability, acceptability of the dressing", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "pain evaluation", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "overall cost regarding dressing wear time", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "Molnlycke Health Care AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Molnlycke Health Care AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}